Foschini M P, Dina R E, Eusebi V
Department of Pathology, University of Bologna, Italy.
Semin Diagn Pathol. 1993 May;10(2):128-36.
Biphasic sarcomatoid carcinomas (SC) of the breast are defined as tumors that are composed of overtly carcinomatous and sarcoma-like elements and were known in the past as "carcinosarcomas." On the other hand, monophasic SC show features that are similar to those of sarcomas, but epithelial differentiation is detected in the former of these lesions by immunohistochemical methods. Adequate tissue sampling often is required to demonstrate both components of biphasic SC; if properly performed, this procedure greatly reduces the diagnosis of true mammary "sarcoma." The carcinomatous element of biphasic tumors is characterized either by features of a squamous carcinoma or an invasive ductal adenocarcinoma. Squamous differentiation is more often associated with a spindle-cell, fibrosarcoma-like, or malignant fibrous histiocytoma (MFH)-like sarcomatoid component, whereas adenocarcinomas usually are admixed with sarcoma-like tissues having "heterologous" properties. The overtly epithelial elements of biphasic SC are always immunoreactive for keratin, but areas that simulate sarcoma express this protein more heterogeneously. Both components may show positivity for vimentin, although the sarcoma-like elements do so more consistently. Monophasic SC is composed solely of fusiform and pleomorphic cells that are keratin-positive despite their mimicry of sarcomatous differentiation. This tumor variant commonly assumes a myxoid, angiomatoid, or storiform growth pattern, without recognizable carcinomatous foci by light microscopy. Prognosis and involvement of regional lymph nodes in mammary SC cases is controversial, because different tumors have been grouped together in the past for the analysis of these variables. However, SC generally has a less favorable outcome than that of ordinary invasive carcinomas of the breast.(ABSTRACT TRUNCATED AT 250 WORDS)
乳腺双相性肉瘤样癌(SC)被定义为由明显的癌性和肉瘤样成分组成的肿瘤,过去被称为“癌肉瘤”。另一方面,单相性SC表现出与肉瘤相似的特征,但通过免疫组织化学方法在前一种病变中可检测到上皮分化。通常需要足够的组织采样来显示双相性SC的两种成分;如果操作得当,此程序可大大减少对真正乳腺“肉瘤”的诊断。双相性肿瘤的癌性成分特征为鳞状细胞癌或浸润性导管腺癌的特征。鳞状分化更常与梭形细胞、纤维肉瘤样或恶性纤维组织细胞瘤(MFH)样肉瘤样成分相关,而腺癌通常与具有“异源性”特性的肉瘤样组织混合。双相性SC明显的上皮成分对角蛋白总是呈免疫反应性,但模拟肉瘤的区域对这种蛋白的表达更不均匀。两种成分对波形蛋白都可能呈阳性,尽管肉瘤样成分更一致。单相性SC仅由梭形和多形性细胞组成,尽管它们模拟肉瘤样分化,但对角蛋白呈阳性。这种肿瘤变体通常呈现黏液样、血管瘤样或席纹状生长模式,在光学显微镜下无明显的癌灶。乳腺SC病例的预后和区域淋巴结受累情况存在争议,因为过去不同的肿瘤被归为一组来分析这些变量。然而,SC的总体预后通常比普通乳腺浸润性癌更差。(摘要截短于250字)